Diabetologia

Up front

Vascular complications in diabetes: old messages, new thoughts

Josephine M. Forbes, Amelia K. Fotheringham

Understanding and preventing type 1 diabetes through the unique working model of TrialNet

Manuela Battaglia, Mark S. Anderson, Jane H. Buckner, Susan M. Geyer, Peter A. Gottlieb, Thomas W. H. Kay, Åke Lernmark, Sarah Muller, Alberto Pugliese, Bart O. Roep, Carla J. Greenbaum, Mark Peakman

Should we screen for type 2 diabetes among asymptomatic individuals? Yes

David Simmons, Janice C. Zgibor

Does the evidence support population-wide screening for type 2 diabetes? No

Jonathan E. Shaw

Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial

Klemen Dovc, Maddalena Macedoni, Natasa Bratina, Dusanka Lepej, Revital Nimri, Eran Atlas, Ido Muller, Olga Kordonouri, Torben Biester, Thomas Danne, Moshe Phillip, Tadej Battelino

Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement

Timothy J. McDonald, Rachel E. Besser, Mandy Perry, Tarig Babiker, Bridget A. Knight, Maggie H. Shepherd, Sian Ellard, Sarah E. Flanagan, Andrew T. Hattersley

Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine

Antonio Eleuteri, Anthony C. Fisher, Deborah M. Broadbent, Marta García-Fiñana, Christopher P. Cheyne, Amu Wang, Irene M. Stratton, Mark Gabbay, Daniel Seddon, Simon P. Harding

Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults

Rebecca K. Simmons, Simon J. Griffin, Daniel R. Witte, Knut Borch-Johnsen, Torsten Lauritzen, Annelli Sandbæk

Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009

Rebecca K. Simmons, Simon J. Griffin, Torsten Lauritzen, Annelli Sandbæk

Screening for type 2 diabetes: do screen-detected cases fare better?

Adina L. Feldman, Simon J. Griffin, Eva Fhärm, Margareta Norberg, Patrik Wennberg, Lars Weinehall, Olov Rolandsson

The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study

Lin Xu, Maria Carolina Borges, Gibran Hemani, Debbie A. Lawlor

Perceived racism and incident diabetes in the Black Women’s Health Study

Kathryn L. Bacon, Sherri O. Stuver, Yvette C. Cozier, Julie R. Palmer, Lynn Rosenberg, Edward A. Ruiz-Narváez

Immigration to Israel during childhood is associated with diabetes at adolescence: a study of 2.7 million adolescents

Alon Peled, Barak Gordon, Gilad Twig, Joseph Mendlovic, Estela Derazne, Michal Lisnyansky, Itamar Raz, Arnon Afek

Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes

Adem Y. Dawed, Ashfaq Ali, Kaixin Zhou, Ewan R. Pearson, Paul W. Franks

Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion

Felicia Gerst, Robert Wagner, Gabriele Kaiser, Madhura Panse, Martin Heni, Jürgen Machann, Malte N. Bongers, Tina Sartorius, Bence Sipos, Falko Fend, Christian Thiel, Silvio Nadalin, Alfred Königsrainer, Norbert Stefan, Andreas Fritsche, Hans-Ulrich Häring, Susanne Ullrich, Dorothea Siegel-Axel

Relapsing/remitting type 1 diabetes

Kayleigh M. van Megen, Matthew P. Spindler, Fleur M. Keij, Ineke Bosch, Fleur Sprangers, Annet van Royen-Kerkhof, Tatjana Nikolic, Bart O. Roep

The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse

Danielle J. Borg, Ran Wang, Lydia Murray, Hui Tong, Raymond J. Steptoe, Michael A. McGuckin, Sumaira Z. Hasnain

VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells

Gaia Botteri, Marta Montori, Anna Gumà, Javier Pizarro, Lídia Cedó, Joan Carles Escolà-Gil, Diana Li, Emma Barroso, Xavier Palomer, Alison B. Kohan, Manuel Vázquez-Carrera

FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes

Thomas Laeger, Christian Baumeier, Ilka Wilhelmi, Josefine Würfel, Anne Kamitz, Annette Schürmann

Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes

Cristina Hernández, Patricia Bogdanov, Cristina Solà-Adell, Joel Sampedro, Marta Valeri, Xavier Genís, Olga Simó-Servat, Marta García-Ramírez, Rafael Simó

Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor

Abigail C. Lay, Jenny A. Hurcombe, Virginie M. S. Betin, Fern Barrington, Ruth Rollason, Lan Ni, Lawrence Gillam, Grace M. E. Pearson, Mette V. Østergaard, Hellyeh Hamidi, Rachel Lennon, Gavin I. Welsh, Richard J. M. Coward

Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy

Chinmay S. Marathe, Christopher K. Rayner, Karen L. Jones, Michael Horowitz

Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy. Reply to Marathe CS, Rayner CK, Jones KL, et al [letter]

Adam D. Farmer, Anne Grave Pedersen, Birgitte Brock, Poul Erik Jakobsen, Jesper Karmisholt, Sahar D. Mohammed, S. Mark Scott, Asbjørn Mohr Drewes, Christina Brock